Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
NCT00929669
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
unable to identify a third subject
Conditions
Gonadotroph Adenomas
Interventions
DRUG:
pasireotide LAR
Sponsor
University of Pennsylvania